Active Surveillance for Screen-detected Low- and Intermediate-risk Prostate Cancer: Extended Follow-up up to 25 Years in the GÖTEBORG-1 Trial
Uro-Oncology
Related content
Further Publications Urology
Impact of Holmium Laser Enucleation of the Prostate on Active Surveillance for Prostate Cancer in Patients With Lower Urinary Tract Symptoms
Prostate
Bâcle C, Mazancourt ES, Abid N, Ruffion A, Rouvière O, Colombel M, Fassi-Fehri H
doi: 10.1002/pros.24906
COMMENTED
Uro-Oncology
Persistent Prostate-Specific Antigen Following Radical Prostatectomy for Prostate Cancer and Mortality Risk
★ 1
Recommended and commented by
Prof. Dr Richard Cathomas, Faculty Member
JAMA Oncol
Tilki D, Chen MH, Wu J, Huland H, Graefen M, Trock BJ, Han M, D'Amico AV
doi: 10.1001/jamaoncol.2025.0110
Uro-Oncology
History of Vasectomy Is not Associated With Prostate Cancer Progression in Men on Active Surveillance
Prostate
Grutman AJ, Jing Y, Ng DK, Landis PK, Trock BJ, Pavlovich CP
doi: 10.1002/pros.70001
Uro-Oncology
Prostate Cancer Detection in Younger Men: A Comparative Analysis of Systematic and Magnetic Resonance Imaging-targeted Biopsy in the PROBASE Trial
Eur Urol
Al-Monajjed R, Boschheidgen M, Lakes J, Krilaviciute A, Radtke JP, Schlemmer HP, Bonekamp D, Herkommer K, Jahnen M, Gschwend JE, Düx D, Wacker F, Makowski MR, Sauter A, Kuczyk MA, Harke N, Debus J, Grott C, Arsov C, Seibold P, Hadaschik B, Giesel F, Kristiansen G, Antoch G, Becker N, Kaaks R, Schimmöller L, Albers P
doi: 10.1016/j.eururo.2025.05.020
Uro-Oncology
Prospective study of endogenous testosterone recovery following neoadjuvant hormonal blockade and radical prostatectomy in high-risk prostate cancer patients
J Sex Med
Nascimento BCG, Pedrenho R, Zandoná PCE, Sanvido LV, Bessa Junior J, Miranda EP, Bastos DA, Cordeiro MD, Coelho R, Nahas WC, Hallak J, Mulhall JP, Gomes CM
doi: 10.1093/jsxmed/qdaf164
Uro-Oncology
Hypofractionated radiotherapy for prostate cancer (HYDRA): an individual patient data meta-analysis of randomised trials in the MARCAP consortium
Lancet Oncol
Kishan AU, Sun Y, Tree AC, Hall E, Dearnaley D, Catton CN, Lukka HR, Pond G, Lee WR, Sandler HM, Feng FY, Nguyen PL, Incrocci L, Heemsbergen W, Pos FJ, Horwitz E, Wong JK, Hoffman KE, Hassanzadeh C, Kuban DA, Arcangeli S, Sanguineti G, Supiot S, Crehange G, Latorzeff I, Kalbasi TR, Steinberg ML, Valle LF, Loblaw A, Nikitas J, Roy S, Zaorsky NG, Jia AY, Spratt DE
doi: 10.1016/S1470-2045(25)00034-8
Uro-Oncology
Positive surgical margin and oncological outcomes after robot-assisted radical prostatectomy in different Cancer of the Prostate Risk Assessment risk groups
BJU Int
Hagman A, Lantz A, Grannas D, Carlsson S, Akre O, Olsson M, Egevad L, Höijer J, Wiklund P
doi: 10.1111/bju.16732
Uro-Oncology
Defining Abnormal Prostate Specific Antigen Values for Prostate Cancer Screening in the Spinal Cord Injury Population
J Urol
Fogg RW, Krzastek SC, Vissichelli N, Defor E, Sabo R, Ghatas M, Sima A, Swavely N, Grob BM, Carter W, Goetz L, Klausner AP
doi: 10.1097/JU.0000000000004644
Uro-Oncology
Efficacy and Feasibility of Cabazitaxel for Very Elderly Patients of ≥ 80 Years of Age With Metastatic Castration-Resistant Prostate Cancer: A Real-World Multi-Intuitional Analysis
Prostate
Suzuki K, Hirata J, Okamura Y, Bando Y, Hara T, Terakawa T, Hyodo Y, Chiba K, Teishima J, Miyake H
doi: 10.1002/pros.24889